SLN-COPA

**SLN-COPA** is an experimental **solid lipid nanoparticle formulation** built from babassu oil and **copaiba oleoresin** and investigated as a potential therapy for **prostate cancer**. Based on the provided publication, it is not a conventional single-entity pharmaceutical but a **nanoparticle delivery formulation** in which copaiba oleoresin is incorporated into a lipid matrix; formulations containing babassu oil and copaiba oleoresin in a 1:1 ratio showed in vitro cytotoxic activity against PC-3 and DU-145 prostate cancer cell lines. Its antitumor activity appears to derive from the bioactive natural-product constituents of copaiba oleoresin, such as **beta-caryophyllene**, delivered within a stabilized lipid nanoparticle system rather than from a well-defined, validated molecular target or clinically established mechanism.

Other names

solid lipid nanoparticles containing copaiba oleoresincopaiba oleoresin-loaded solid lipid nanoparticlesbabassu oil and copaiba oleoresin solid lipid nanoparticles